Cargando…
MyD88-dependent interplay between myeloid and endothelial cells in the initiation and progression of obesity-associated inflammatory diseases
Low-grade systemic inflammation is often associated with metabolic syndrome, which plays a critical role in the development of the obesity-associated inflammatory diseases, including insulin resistance and atherosclerosis. Here, we investigate how Toll-like receptor–MyD88 signaling in myeloid and en...
Autores principales: | Yu, Minjia, Zhou, Hao, Zhao, Junjie, Xiao, Nengming, Roychowdhury, Sanjoy, Schmitt, David, Hu, Bingqing, Ransohoff, Richard M., Harding, Clifford V., Hise, Amy G., Hazen, Stanley L., DeFranco, Anthony L., Fox, Paul L., Morton, Richard E., Dicorleto, Paul E., Febbraio, Maria, Nagy, Laura E., Smith, Jonathan D., Wang, Jian-an, Li, Xiaoxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010914/ https://www.ncbi.nlm.nih.gov/pubmed/24752299 http://dx.doi.org/10.1084/jem.20131314 |
Ejemplares similares
-
MyD88-dependent interplay between myeloid and endothelial cells in the initiation and progression of obesity-associated inflammatory diseases
por: Yu, Minjia, et al.
Publicado: (2014) -
Mucus clearance, MyD88-dependent and MyD88-independent immunity modulate lung susceptibility to spontaneous bacterial infection and inflammation
por: Livraghi-Butrico, Alessandra, et al.
Publicado: (2012) -
MyD88 and beyond: a perspective on MyD88-targeted therapeutic approach for modulation of host immunity
por: Saikh, Kamal U.
Publicado: (2021) -
Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88‐Dependent Inflammation
por: Luo, Wu, et al.
Publicado: (2022) -
MyD88 contribution to ocular surface homeostasis
por: Reins, Rose Y., et al.
Publicado: (2017)